544529 — Aptus Pharma Balance Sheet
0.000.00%
- IN₹615.96m
- IN₹719.53m
- IN₹245.58m
Annual balance sheet for Aptus Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Cash and Short Term Investments | 5.37 | 9.15 | 52.1 |
Net Total Accounts Receivable | |||
Net Total Receivables | 28.2 | 39.8 | 74.6 |
Total Inventory | |||
Total Other Current Assets | |||
Total Current Assets | 56.5 | 83.2 | 197 |
Net Property, Plant And Equipment | 5.14 | 6.17 | 9.63 |
Net Intangible Assets | |||
Other Long Term Assets | |||
Total Assets | 62.2 | 100 | 219 |
Accounts Payable | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 31.3 | 41.4 | 121 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Total Other Liabilities | |||
Total Liabilities | 52.5 | 82.6 | 150 |
Common Stock | |||
Retained Earnings (Accumulated Deficit) | |||
Total Equity | 9.68 | 17.7 | 69.7 |
Total Liabilities & Shareholders' Equity | 62.2 | 100 | 219 |
Total Common Shares Outstanding |